COVID-19 vaccines and myocarditis

Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):515-517. doi: 10.1016/j.acvd.2021.06.001. Epub 2021 Jun 26.

Authors

Mathieu Kerneis¹, Kevin Bihan², Joe-Elie Salem²

Affiliations

¹ Sorbonne Université, ACTION Study Group, INSERM UMRS1166, ICAN-Institute of CardioMetabolism and Nutrition, Institut de Cardiologie, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, 75013 Paris, France. Electronic address: mathieu.kerneis@aphp.fr.
² Sorbonne Université, Clinical Investigations Center Paris-Est, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, INSERM, 75013 Paris, France.

No abstract available

Keywords: COVID-19; Myocardite; Myocarditis; Pharmacovigilance; Vaccin; Vaccines.

Publication types

Letter

MeSH terms

Adult
COVID-19 / epidemiology
COVID-19 / therapy*
COVID-19 Vaccines / adverse effects*
Europe / epidemiology
Female
Humans
Incidence
Male
Middle Aged
Myocarditis / chemically induced*
Myocarditis / epidemiology
SARS-CoV-2 / immunology*
Young Adult

Substances

COVID-19 Vaccines